Nanochon, a cultivate(MD) portfolio company developing an implant for treating articular cartilage defects in the knee, has secured commitments to close an oversubscribed funding round, bringing its total capital raised to date to $11.3 million. The round was led by cultivate (MD), with significant contributions from The University of Virginia UVA Seed Fund, WSGR, Wealthing […]
Nanochon closes $4.1M Seed Prime II Funding Round Read More »
First-in-human procedures mark a critical milestone supporting the system’s clinical development Prana Surgical, a cultivate(MD) portfolio company, announced the completion of the first five clinical procedures using the Prana System™ as part of its early feasibility study in Australia. The Prana System™ has been developed to enable image-guided, minimally invasive surgery, conserving healthy tissue and
Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Shoulder Innovations (NYSE: SI), a cultivate(MD) portfolio company, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-specific micro-robotic solution designed to further
HAPPE Spine, a cultivate(MD) portfolio company with a proprietary biomaterial and manufacturing platform for creating bone-integrating implants, announces that the INTEGRATE®-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE® platform across more than 30 surgeon users and 40 facilities nationwide.
HAPPE Spine Reaches 1,000 Patients Read More »
Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the third quarter ended September 30, 2025. Third Quarter & Recent Business Highlights “We are very excited about our accelerating momentum through 2025, with first-half year-over-year revenue growth of 37% expanding to 58% in the third quarter,
Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio Grand Rapids, MI – September 22, 2025 – Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem (“InSet™ 70”). The
Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem Read More »
